231 related articles for article (PubMed ID: 17878362)
1. A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.
Rowland SL; Tremblay MM; Ellison JM; Stunz LL; Bishop GA; Hostager BS
J Immunol; 2007 Oct; 179(7):4645-53. PubMed ID: 17878362
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.
Hostager BS; Haxhinasto SA; Rowland SL; Bishop GA
J Biol Chem; 2003 Nov; 278(46):45382-90. PubMed ID: 12958312
[TBL] [Abstract][Full Text] [Related]
3. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.
Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA
J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006
[TBL] [Abstract][Full Text] [Related]
5. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages.
Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J
J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933
[TBL] [Abstract][Full Text] [Related]
6. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
7. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions.
Jalukar SV; Hostager BS; Bishop GA
J Immunol; 2000 Jan; 164(2):623-30. PubMed ID: 10623803
[TBL] [Abstract][Full Text] [Related]
9. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation.
Munroe ME; Bishop GA
J Biol Chem; 2004 Dec; 279(51):53222-31. PubMed ID: 15485859
[TBL] [Abstract][Full Text] [Related]
10. TRAF2 Ser-11 Phosphorylation Promotes Cytosolic Translocation of the CD40 Complex To Regulate Downstream Signaling Pathways.
Workman LM; Zhang L; Fan Y; Zhang W; Habelhah H
Mol Cell Biol; 2020 Apr; 40(9):. PubMed ID: 32041822
[TBL] [Abstract][Full Text] [Related]
11. TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells.
Davies CC; Mak TW; Young LS; Eliopoulos AG
Mol Cell Biol; 2005 Nov; 25(22):9806-19. PubMed ID: 16260598
[TBL] [Abstract][Full Text] [Related]
12. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K.
Benson RJ; Hostager BS; Bishop GA
Eur J Immunol; 2006 Sep; 36(9):2535-43. PubMed ID: 16897814
[TBL] [Abstract][Full Text] [Related]
13. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
[TBL] [Abstract][Full Text] [Related]
15. Roles of TRAF6 in CD40 signaling.
Hostager BS
Immunol Res; 2007; 39(1-3):105-14. PubMed ID: 17917059
[TBL] [Abstract][Full Text] [Related]
16. Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.
Portillo JA; Greene JA; Schwartz I; Subauste MC; Subauste CS
Immunology; 2015 Jan; 144(1):21-33. PubMed ID: 25051892
[TBL] [Abstract][Full Text] [Related]
17. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
[TBL] [Abstract][Full Text] [Related]
18. HOIL-1L interacting protein (HOIP) is essential for CD40 signaling.
Hostager BS; Kashiwada M; Colgan JD; Rothman PB
PLoS One; 2011; 6(8):e23061. PubMed ID: 21829693
[TBL] [Abstract][Full Text] [Related]
19. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
Pullen SS; Dang TT; Crute JJ; Kehry MR
J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
[TBL] [Abstract][Full Text] [Related]
20. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.
Lutgens E; Lievens D; Beckers L; Wijnands E; Soehnlein O; Zernecke A; Seijkens T; Engel D; Cleutjens J; Keller AM; Naik SH; Boon L; Oufella HA; Mallat Z; Ahonen CL; Noelle RJ; de Winther MP; Daemen MJ; Biessen EA; Weber C
J Exp Med; 2010 Feb; 207(2):391-404. PubMed ID: 20100871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
